Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
EnerSys
NYSE:ENS
|
US |
Pharma Equity Group A/S
Total Current Assets
Pharma Equity Group A/S
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Total Current Assets
kr38.3m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
229%
|
CAGR 10-Years
30%
|
|
|
Jeudan A/S
CSE:JDAN
|
Total Current Assets
kr398.1m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Total Current Assets
kr4m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Total Current Assets
kr188.5m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
37%
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Total Current Assets
kr83.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
-5%
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Total Current Assets
kr25.2m
|
CAGR 3-Years
48%
|
CAGR 5-Years
26%
|
CAGR 10-Years
21%
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
See Also
What is Pharma Equity Group A/S's Total Current Assets?
Total Current Assets
38.3m
DKK
Based on the financial report for Dec 31, 2025, Pharma Equity Group A/S's Total Current Assets amounts to 38.3m DKK.
What is Pharma Equity Group A/S's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
30%
Over the last year, the Total Current Assets growth was -22%. The average annual Total Current Assets growth rates for Pharma Equity Group A/S have been -19% over the past three years , 229% over the past five years , and 30% over the past ten years .
